Cargando…
HLA‐E: exploiting pathogen‐host interactions for vaccine development
Viruses, when used as vectors for vaccine antigen delivery, can induce strong cellular and humoral responses against target epitopes. Recent work by Hansen et al. describes the use of a cytomegalovirus‐vectored vaccine, which is able to generate a stable effector‐memory T cell population at the site...
Autores principales: | Sharpe, H. R., Bowyer, G., Brackenridge, S., Lambe, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468186/ https://www.ncbi.nlm.nih.gov/pubmed/30968409 http://dx.doi.org/10.1111/cei.13292 |
Ejemplares similares
-
Vaccines for emerging pathogens: from research to the clinic
por: Williamson, E. D.
Publicado: (2019) -
Emerging viruses and current strategies for vaccine intervention
por: Afrough, B., et al.
Publicado: (2019) -
Novel approaches for the design, delivery and administration of vaccine technologies
por: Wallis, J., et al.
Publicado: (2019) -
Mucosal vaccines and technology
por: Miquel‐Clopés, A., et al.
Publicado: (2019) -
Vaccines for emerging pathogens: prospects for licensure
por: Williamson, E. D., et al.
Publicado: (2019)